Such companies can be wonderful options for income-seeking investments. If you're in the market for that combo, let's ...
AbbVie's strong earnings and growth projections make it a solid buy for 2025, with no major patent expirations until 2030. Learn more on ABBV stock here.
6d
24/7 Wall St. on MSNAbbVie (ABBV) Earnings Live: Why The Stock Is Up Big TodayLive Updates Deep Dive into ABBV's Earnings Call 11:53 am Looking through AbbVie’s earnings call, these growth prospects stood out: 1. Skyrizi & Rinvoq Set to Dominate Immunology Market 2025 revenue ...
Today, quip, the pioneering design-led oral wellness company, is proud to announce the launch of its groundbreaking innovation: the quip Ultra Next Generation Smart Sonic Toothbrush. Designed in ...
The last pair of Patent Plaques from Intel just arrived! Patents are formal ways of showcasing novelty and problem-solving skills without having to worry about NDAs or confidentiality agreements.
When I first told my dentist about the Feno Smartbrush, eyebrows were raised. “Don’t use that,” she quipped as I explained ...
Vanda and AnaptysBio have announced an exclusive worldwide licence agreement to develop and commercialise imsidolimab to ...
Schools, museums and communities across the nation are marking Black History Month — a celebration of Black history, culture ...
The US Senate has come together to pass a bill that aims to prevent pharma companies from filing multiple patents around biologic drugs as a way to delay biosimilar competitors. Lawmakers ...
Twenty years ago, Congress began hearing that the patent system needed a faster, cheaper way than district court suits to assess the validity of issued patents. In line with this goal, Congress ...
Take a step back in time with our weekly feature looking back at top headlines and photos of yesteryear.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results